Trial Profile
Randomized, Double Blind, Placebo-Controlled Clinical Trial Evaluating Ramelteon in the Prevention of Delirium
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2020
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 31 Jul 2018 Planned End Date changed from 1 Aug 2017 to 1 Jun 2019.
- 31 Jul 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2018.
- 28 Mar 2017 Status changed from active, no longer recruiting to recruiting.